Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)

18 May 2025 (15:02 - 15:10)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)

5 More presentations in this session

Presentation thumbnail

Welcome and introduction

Professor M. Cikes (Zagreb, HR)

Presentation thumbnail

MRAs in heart failure with reduced rejection fraction (HFrEF): a cornerstone of guideline-recommended medical therapy

Professor M. Cikes (Zagreb, HR)

Presentation thumbnail

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

Professor J. Butler (Dallas, US)

Presentation thumbnail

nsMRAs: what emerging trials tell us about the future of heart failure therapy

Professor J. McMurray (Glasgow, GB)

Presentation thumbnail

Panel discussion and conclusion

Access the full session

Session thumbnail

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

The Event

Event poster

Heart Failure 2025

18 May 2025 15:02 CET

You may be interested in

Congress Presentation

Transforming CKM syndrome and HFmrEF/HFpEF management: long-term estimated benefits of integrated strategies

Congress Presentation

SGLT2i, finerenone, and beyond: orchestrating the cardiorenal quartet

Congress Presentation

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources